BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 31313295)

  • 1. YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy.
    Han N; Tian W; Yu N; Yu L
    J Cell Physiol; 2020 Feb; 235(2):1309-1320. PubMed ID: 31313295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA MALAT1 participates in the pathological angiogenesis of diabetic retinopathy in an oxygen-induced retinopathy mouse model by sponging miR-203a-3p.
    Yu L; Fu J; Yu N; Wu Y; Han N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):219-227. PubMed ID: 31689123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion.
    Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.
    Tang W; Guo J; Gu R; Lei B; Ding X; Ma J; Xu G
    Mol Vis; 2020; 26():64-75. PubMed ID: 32165827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
    Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
    [No Abstract]   [Full Text] [Related]  

  • 7. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis.
    Tan A; Li T; Ruan L; Yang J; Luo Y; Li L; Wu X
    Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p.
    Li X
    Arch Physiol Biochem; 2024 Apr; 130(2):119-127. PubMed ID: 34674599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-384-3p inhibits retinal neovascularization through targeting hexokinase 2 in mice with diabetic retinopathy.
    Xia F; Sun JJ; Jiang YQ; Li CF
    J Cell Physiol; 2018 Jan; 234(1):721-730. PubMed ID: 30191948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding ribonucleic acid urothelial carcinoma-associated 1 promotes high glucose-induced human retinal endothelial cells angiogenesis through regulating micro-ribonucleic acid-624-3p/vascular endothelial growth factor C.
    Yan H; Yao P; Hu K; Li X; Li H
    J Diabetes Investig; 2021 Nov; 12(11):1948-1957. PubMed ID: 34137197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel regulatory network of linc00174/miR-150-5p/VEGFA modulates pathological angiogenesis in diabetic retinopathy.
    Wang JJ; Wu KF; Wang DD
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1175-1183. PubMed ID: 34081870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT1 aggravates the retinal angiogenesis via miR-320a/HIF-1α axis in diabetic retinopathy.
    Chen Z; Yang J; Gao Y; Jiang S; Li Z; Wang Y; Hu Z; Han F; Ni N
    Exp Eye Res; 2022 May; 218():108984. PubMed ID: 35202706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-Regulation of circCOL1A2 Suppresses the Dysfunction of Diabetes-Related Retinal Microvascular Endothelial Cells via miR-646/FGF7 Axis.
    Cao H; Xu X; Wang K; Li C
    Curr Eye Res; 2022 Nov; 47(11):1525-1533. PubMed ID: 35924466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
    McArthur K; Feng B; Wu Y; Chen S; Chakrabarti S
    Diabetes; 2011 Apr; 60(4):1314-23. PubMed ID: 21357793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes.
    Wang S; Du S; Lv Y; Wang W; Zhang F
    IUBMB Life; 2020 Jul; 72(7):1433-1448. PubMed ID: 32150340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.
    Wang Y; Lin W; Ju J
    Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XIST promotes neovascularization in diabetic retinopathy by regulating miR-101-3p/VEGFA.
    Fu W; Ye Y; Hu F
    Arch Endocrinol Metab; 2024 May; 68():e230097. PubMed ID: 38739522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of endothelial to mesenchymal transition in the retina in diabetes.
    Cao Y; Feng B; Chen S; Chu Y; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7321-31. PubMed ID: 25335984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.